Abstract 2521: Targeting CD44 in head and neck squamous cell carcinoma (HNSCC) with a new humanized antibody RO5429083

Journal article

Peer reviewed

Aymee Perez, David M Neskey, Judy Wen, Jarrard W Goodwin, Joyce Slingerland, Lutecia Pereira, Stefan Weigand and Elizabeth J Franzmann

Cancer research (Chicago, Ill.), Vol.72(8 Supplement), pp.2521-2521

2012-04-15

Metrics

16 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.264 Longevity; 1.264.618 Caenorhabditis Elegans
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Abstract 2521: Targeting CD44 in head and neck squamous cell carcinoma (HNSCC) with a new humanized antibody RO5429083
Creators: Aymee Perez
David M Neskey
Judy Wen
Jarrard W Goodwin
Joyce Slingerland
Lutecia Pereira
Stefan Weigand
Elizabeth J Franzmann
Publication Details: Cancer research (Chicago, Ill.), Vol.72(8 Supplement), pp.2521-2521
Academic Unit: Miller School of Medicine; UMMG Department of Otolaryngology
Language: English
Resource Type: Journal article
Record Identifier: 991031598575702976